Hypothyroidism as a risk factor for cardiovascular disease

被引:265
作者
Biondi, B
Klein, I [1 ]
机构
[1] N Shore Univ Hosp, Div Endocrinol, Manhasset, NY 11030 USA
[2] Univ Naples Federico II, Sch Med, Dept Clin & Mol Endocrinol & Oncol, I-80131 Naples, Italy
[3] N Shore Univ Hosp, Dept Med, Manhasset, NY 11030 USA
[4] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA
关键词
subclinical hypothyroidism; mild thyroid failure; atherosclerosis; hypertension; endothelial dysfunction; homocysteine; C-reactive protein; lipid metabolism; heart failure;
D O I
10.1385/ENDO:24:1:001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The cardiovascular risk in patients with hypothyroidism is related to an increased risk of functional cardiovascular abnormalities and to an increased risk of atherosclerosis. The pattern of cardiovascular abnormalities is similar in subclinical and overt hypothyroidism, suggesting that a lesser degree of thyroid hormone deficiency may also affect the cardiovascular system. Hypothyroid patients, even those with subclinical hypothyroidism, have impaired endothelial function, normal/depressed systolic function, left ventricular diastolic dysfunction at rest, and systolic and diastolic dysfunction on effort, which may result in poor physical exercise capacity. There is also a tendency to increase diastolic blood pressure as a result of increased systemic vascular resistance. All these abnormalities regress with L-T 4 replacement therapy. An increased risk for atherosclerosis is supported by autopsy and epidemiological studies in patients with thyroid hormone deficiency. The "traditional" risk factors are hypertension in conjunction with an atherogenic lipid profile; the latter is more often observed in patients with TSH >10 mU/L. More recently, C-reactive protein, homocysteine, increased arterial stiffness, endothelial dysfunction, and altered coagulation parameters have been recognized as risk factors for atherosclerosis in patients with thyroid hormone deficiency. This constellation of reversible cardiovascular abnormalities in patient with TSH levels <10 mU/L indicate that the benefits of treatment of mild thyroid failure with appropriate doses Of L-thyroxine outweigh the risk.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 161 条
[1]   EFFECT OF THYROID STATE ON MYOCARDIAL CONTRACTILITY AND VENTRICULAR EJECTION RATE IN MAN [J].
AMIDI, M ;
LEON, DF ;
DEGROOT, WJ ;
KROETZ, FW ;
LEONARD, JJ .
CIRCULATION, 1968, 38 (02) :229-&
[2]   Narrow individual variations in serum T4 and T3 in normal subjects:: A clue to the understanding of subclinical thyroid disease [J].
Andersen, S ;
Pedersen, KM ;
Bruun, NH ;
Laurberg, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) :1068-1072
[3]   Evaluation and management of diastolic heart failure [J].
Angeja, BG ;
Grossman, W .
CIRCULATION, 2003, 107 (05) :659-663
[4]  
[Anonymous], 2003, THYROID, V13, P3
[5]  
ANTHONISEN P, 1960, SCAND J CLIN LAB INV, V12, P472
[6]   Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a) [J].
Arem, R ;
Escalante, DA ;
Arem, N ;
Morrisett, JD ;
Patsch, W .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (12) :1559-1563
[7]   Thyroid function is associated with presence and severity of coronary atherosclerosis [J].
Auer, J ;
Berent, R ;
Weber, T ;
Lassnig, E ;
Eber, B .
CLINICAL CARDIOLOGY, 2003, 26 (12) :569-573
[8]   The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects [J].
Bakker, SJL ;
ter Maaten, JC ;
Popp-Snijders, C ;
Slaets, JPJ ;
Heine, RJ ;
Gans, ROB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1206-1211
[9]   Homocysteine, folate, vitamin B12, and transcobalamins in patients undergoing successive hypo- and hyperthyroid states [J].
Barbé, F ;
Klein, M ;
Chango, A ;
Frémont, S ;
Gérard, P ;
Weryha, G ;
Guéant, JL ;
Nicolas, JP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1845-1846
[10]   PROGRESSION AND REGRESSION OF HUMAN CORONARY ATHEROSCLEROSIS - THE ROLE OF LIPOPROTEINS, LIPASES AND THYROID-HORMONES IN CORONARY LESION GROWTH [J].
BARTH, JD ;
JANSEN, H ;
KROMHOUT, D ;
REIBER, JHC ;
BIRKENHAGER, JC ;
ARNTZENIUS, AC .
ATHEROSCLEROSIS, 1987, 68 (1-2) :51-58